BioSpace News Archive

BioPharmX (NYSE American: BPMX) (the “Company”), a specialty pharmaceutical company developing products for the dermatology market, received a notice on September 24, 2018 from the NYSE American LLC (the “NYSE American”) that the Company is not in compliance with the stockholders’ equity requirements set forth in Sections 1003(a)(i)-(iii) of the NYSE American Company Guide.

ProtoKinetix Inc. (www.protokinetix.com) (the “Company” or “ProtoKinetix”) (OTCQB:PKTX) Is pleased to announce the launch of a proof of concept study in the field of cardiovascular sciences.

Injured veterans and guests used state-of-the-art laser guns to simulate an energy-charged combat mission during a recent Wounded Warrior Project® (WWP) connection event.

MTF Biologics is expanding its portfolio of innovations for post-mastectomy breast reconstruction with the launch of an acellular dermal matrix (ADM) designed specifically for pre-pectoral breast reconstruction procedures: FlexHD Pliable PRE.

Clarius Mobile Health is introducing the Clarius Cart at the American College of Emergency Physicians (ACEP) 2018 Scientific Assembly.

Infusing the blood supply with new blood donors, strengthening inventory levels and helping to save lives

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) announced today that the company has reached an agreement with the Securities and Exchange Commission (SEC) to fully resolve an investigation into forward-looking financial goals and related disclosures by Walgreen Co. (Walgreens).

SeLux Diagnostics, Inc., which is leading a new era in personalized medicine to treat multi-drug resistant organism infections and combat antibiotic resistance, today announced it has signed a milestone-based contract worth up to $45 million

Henry Ford Health System and Wayne State University announced today the organizations have signed a letter of intent (LOI) to expand their long-term partnership and bring two Detroit anchor institutions even closer together.

Physicians from Texas Oncology will present findings from research projects at ASCO Quality Symposium this week highlighting benefits of an integrated pharmacy model, including studies regarding oral oncolytic therapies, compliance and efficacy with anti-nausea medications, and use of pegfilgrastim.